China Antibiotic Resistance Industry Market Research Report 2023-2029

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report elaborates on the current development of the Antibiotic Resistance industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Tetraphase Pharmaceuticals

    • Westway Health

    • Melinta Therapeutics

    • Nabriva Therapeutics

    • Macrolide Pharmaceuticals

    • Allergan

    • BioVersys GmbH

    • Phage Technologies SA

    • The Medicines Company

    • Nemesis Bioscience

    • AmpliPhi Biosciences

    By Type:

    • Intra-Abdominal Infections

    • Blood Stream Infections

    • Bacterial Pneumonia

    • Acute Bacterial Skin and Skin Structure Infections

    • Clostridium Difficile Infections

    • Urinary Tract Infection

    By Application:

    • Other

    • Combination therapies

    • Tetracyclines

    • Lipoglycopeptides

    • Oxazolidinones

    • Cephalosporins

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Antibiotic Resistance Market Overview 2018-2029

    • 1.1 China Antibiotic Resistance Industry Development Overview

    • 1.2 China Antibiotic Resistance Industry Development History

    • 1.3 China Antibiotic Resistance Industry Market Size (2018-2029)

    • 1.4 China Antibiotic Resistance Market Analysis by Type from Production Side

      • 1.4.1 China Antibiotic Resistance Production Volume, Production Value and Growth Rate of Intra-Abdominal Infections (2018-2029)

      • 1.4.2 China Antibiotic Resistance Production Volume, Production Value and Growth Rate of Blood Stream Infections (2018-2029)

      • 1.4.3 China Antibiotic Resistance Production Volume, Production Value and Growth Rate of Bacterial Pneumonia (2018-2029)

      • 1.4.4 China Antibiotic Resistance Production Volume, Production Value and Growth Rate of Acute Bacterial Skin and Skin Structure Infections (2018-2029)

      • 1.4.5 China Antibiotic Resistance Production Volume, Production Value and Growth Rate of Clostridium Difficile Infections (2018-2029)

      • 1.4.6 China Antibiotic Resistance Production Volume, Production Value and Growth Rate of Urinary Tract Infection (2018-2029)

    • 1.5 China Antibiotic Resistance Market Analysis by Application from Consumption End

      • 1.5.1 China Antibiotic Resistance Sales Volume, Sales Value and Growth Rate of Other (2018-2029)

      • 1.5.2 China Antibiotic Resistance Sales Volume, Sales Value and Growth Rate of Combination therapies (2018-2029)

      • 1.5.3 China Antibiotic Resistance Sales Volume, Sales Value and Growth Rate of Tetracyclines (2018-2029)

      • 1.5.4 China Antibiotic Resistance Sales Volume, Sales Value and Growth Rate of Lipoglycopeptides (2018-2029)

      • 1.5.5 China Antibiotic Resistance Sales Volume, Sales Value and Growth Rate of Oxazolidinones (2018-2029)

      • 1.5.6 China Antibiotic Resistance Sales Volume, Sales Value and Growth Rate of Cephalosporins (2018-2029)

    • 1.6 China Antibiotic Resistance Market Analysis by Region

      • 1.6.1 North China Antibiotic Resistance Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Antibiotic Resistance Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Antibiotic Resistance Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Antibiotic Resistance Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Antibiotic Resistance Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Antibiotic Resistance Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Antibiotic Resistance Market Size and Growth Rate from 2018-2029

    Chapter 2 China Antibiotic Resistance Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Antibiotic Resistance Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Antibiotic Resistance Market Status and Competition Analysis in 2023

      • 2.2.3 China Antibiotic Resistance Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Antibiotic Resistance Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Antibiotic Resistance Industry Development

    Chapter 3 Antibiotic ResistanceIndustry Chain Analysis

    • 3.1 Antibiotic Resistance Industry Chain

    • 3.2 Antibiotic Resistance Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Antibiotic Resistance Market

    • 3.3 Antibiotic Resistance Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Antibiotic Resistance Market

    Chapter 4 China Antibiotic Resistance Market, by Type

    • 4.1 China Antibiotic Resistance Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Antibiotic Resistance Total Production Volume and Growth Rate from Production Side

    • 4.5 China Antibiotic Resistance Production Volume and Growth Rate, by Type

      • 4.5.1 China Antibiotic Resistance Production Volume and Growth Rate of Intra-Abdominal Infections

      • 4.5.2 China Antibiotic Resistance Production Volume and Growth Rate of Blood Stream Infections

      • 4.5.3 China Antibiotic Resistance Production Volume and Growth Rate of Bacterial Pneumonia

      • 4.5.4 China Antibiotic Resistance Production Volume and Growth Rate of Acute Bacterial Skin and Skin Structure Infections

      • 4.5.5 China Antibiotic Resistance Production Volume and Growth Rate of Clostridium Difficile Infections

      • 4.5.6 China Antibiotic Resistance Production Volume and Growth Rate of Urinary Tract Infection

    Chapter 5 China Antibiotic Resistance Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Antibiotic Resistance Total Market Size and Growth Rate from Consumption End

    • 5.5 China Antibiotic Resistance Market Size and Growth Rate, by Application

      • 5.5.1 China Antibiotic Resistance Market Size and Growth Rate of Other

      • 5.5.2 China Antibiotic Resistance Market Size and Growth Rate of Combination therapies

      • 5.5.3 China Antibiotic Resistance Market Size and Growth Rate of Tetracyclines

      • 5.5.4 China Antibiotic Resistance Market Size and Growth Rate of Lipoglycopeptides

      • 5.5.5 China Antibiotic Resistance Market Size and Growth Rate of Oxazolidinones

      • 5.5.6 China Antibiotic Resistance Market Size and Growth Rate of Cephalosporins

    Chapter 6 China Antibiotic Resistance Market, by Region

    • 6.1 China Antibiotic Resistance Production Volume and Production Value, by Region

    • 6.2 China Antibiotic Resistance Sales Volume and Sales Value, by Region

    Chapter 7 North China Antibiotic Resistance Market Analysis

    • 7.1 North China Antibiotic Resistance Market, by Type

    • 7.2 North China Antibiotic Resistance Market, by Application

    Chapter 8 Central China Antibiotic Resistance Market Analysis

    • 8.1 Central China Antibiotic Resistance Market, by Type

    • 8.2 Central China Antibiotic Resistance Market, by Application

    Chapter 9 South China Antibiotic Resistance Market Analysis

    • 9.1 South China Antibiotic Resistance Market, by Type

    • 9.2 South China Antibiotic Resistance Market, by Application

    Chapter 10 East China Antibiotic Resistance Market Analysis

    • 10.1 East China Antibiotic Resistance Market, by Type

    • 10.2 East China Antibiotic Resistance Market, by Application

    Chapter 11 Northeast China Antibiotic Resistance Market Analysis

    • 11.1 Northeast China Antibiotic Resistance Market, by Type

    • 11.2 Northeast China Antibiotic Resistance Market, by Application

    Chapter 12 Southwest China Antibiotic Resistance Market Analysis

    • 12.1 Southwest China Antibiotic Resistance Market, by Type

    • 12.2 Southwest China Antibiotic Resistance Market, by Application

    Chapter 13 Northwest China Antibiotic Resistance Market Analysis

    • 13.1 Northwest China Antibiotic Resistance Market, by Type

    • 13.2 Northwest China Antibiotic Resistance Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Tetraphase Pharmaceuticals

        • 14.1.1 Tetraphase Pharmaceuticals Company Profile

        • 14.1.2 Tetraphase Pharmaceuticals Antibiotic Resistance Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Westway Health

        • 14.2.1 Westway Health Company Profile

        • 14.2.2 Westway Health Antibiotic Resistance Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Melinta Therapeutics

        • 14.3.1 Melinta Therapeutics Company Profile

        • 14.3.2 Melinta Therapeutics Antibiotic Resistance Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Nabriva Therapeutics

        • 14.4.1 Nabriva Therapeutics Company Profile

        • 14.4.2 Nabriva Therapeutics Antibiotic Resistance Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Macrolide Pharmaceuticals

        • 14.5.1 Macrolide Pharmaceuticals Company Profile

        • 14.5.2 Macrolide Pharmaceuticals Antibiotic Resistance Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Allergan

        • 14.6.1 Allergan Company Profile

        • 14.6.2 Allergan Antibiotic Resistance Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 BioVersys GmbH

        • 14.7.1 BioVersys GmbH Company Profile

        • 14.7.2 BioVersys GmbH Antibiotic Resistance Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Phage Technologies SA

        • 14.8.1 Phage Technologies SA Company Profile

        • 14.8.2 Phage Technologies SA Antibiotic Resistance Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 The Medicines Company

        • 14.9.1 The Medicines Company Company Profile

        • 14.9.2 The Medicines Company Antibiotic Resistance Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Nemesis Bioscience

        • 14.10.1 Nemesis Bioscience Company Profile

        • 14.10.2 Nemesis Bioscience Antibiotic Resistance Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 AmpliPhi Biosciences

        • 14.11.1 AmpliPhi Biosciences Company Profile

        • 14.11.2 AmpliPhi Biosciences Antibiotic Resistance Market Performance

        • 14.11.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Antibiotic Resistance Industry Research Conclusions

    • 15.2 Antibiotic Resistance Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Antibiotic Resistance Industry Market Size (2018-2029)

    • Figure China Antibiotic Resistance Production Volume, Production Value and Growth Rate of Intra-Abdominal Infections (2018-2029)

    • Figure China Antibiotic Resistance Production Volume, Production Value and Growth Rate of Blood Stream Infections (2018-2029)

    • Figure China Antibiotic Resistance Production Volume, Production Value and Growth Rate of Bacterial Pneumonia (2018-2029)

    • Figure China Antibiotic Resistance Production Volume, Production Value and Growth Rate of Acute Bacterial Skin and Skin Structure Infections (2018-2029)

    • Figure China Antibiotic Resistance Production Volume, Production Value and Growth Rate of Clostridium Difficile Infections (2018-2029)

    • Figure China Antibiotic Resistance Production Volume, Production Value and Growth Rate of Urinary Tract Infection (2018-2029)

    • Figure China Antibiotic Resistance Sales Volume, Sales Value and Growth Rate of Other (2018-2029)

    • Figure China Antibiotic Resistance Sales Volume, Sales Value and Growth Rate of Combination therapies (2018-2029)

    • Figure China Antibiotic Resistance Sales Volume, Sales Value and Growth Rate of Tetracyclines (2018-2029)

    • Figure China Antibiotic Resistance Sales Volume, Sales Value and Growth Rate of Lipoglycopeptides (2018-2029)

    • Figure China Antibiotic Resistance Sales Volume, Sales Value and Growth Rate of Oxazolidinones (2018-2029)

    • Figure China Antibiotic Resistance Sales Volume, Sales Value and Growth Rate of Cephalosporins (2018-2029)

    • Figure North China Antibiotic Resistance Market Size and Growth Rate from 2018-2029

    • Figure Central China Antibiotic Resistance Market Size and Growth Rate from 2018-2029

    • Figure South China Antibiotic Resistance Market Size and Growth Rate from 2018-2029

    • Figure East China Antibiotic Resistance Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Antibiotic Resistance Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Antibiotic Resistance Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Antibiotic Resistance Market Size and Growth Rate from 2018-2029

    • Figure Antibiotic Resistance Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Antibiotic Resistance Market Share by Type in 2018

    • Figure China Antibiotic Resistance Market Share by Type in 2023

    • Figure China Antibiotic Resistance Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Antibiotic Resistance Production Volume and Growth Rate of Intra-Abdominal Infections (2018-2023)

    • Figure China Antibiotic Resistance Production Volume and Growth Rate of Blood Stream Infections (2018-2023)

    • Figure China Antibiotic Resistance Production Volume and Growth Rate of Bacterial Pneumonia (2018-2023)

    • Figure China Antibiotic Resistance Production Volume and Growth Rate of Acute Bacterial Skin and Skin Structure Infections (2018-2023)

    • Figure China Antibiotic Resistance Production Volume and Growth Rate of Clostridium Difficile Infections (2018-2023)

    • Figure China Antibiotic Resistance Production Volume and Growth Rate of Urinary Tract Infection (2018-2023)

    • Figure China Antibiotic Resistance Market Share by Application in 2018

    • Figure China Antibiotic Resistance Market Share by Application in 2023

    • Figure China Antibiotic Resistance Total Market Size and Growth Rate from Consumption End

    • Figure China Antibiotic Resistance Market Size and Growth Rate of Other (2018-2023)

    • Figure China Antibiotic Resistance Market Size and Growth Rate of Combination therapies (2018-2023)

    • Figure China Antibiotic Resistance Market Size and Growth Rate of Tetracyclines (2018-2023)

    • Figure China Antibiotic Resistance Market Size and Growth Rate of Lipoglycopeptides (2018-2023)

    • Figure China Antibiotic Resistance Market Size and Growth Rate of Oxazolidinones (2018-2023)

    • Figure China Antibiotic Resistance Market Size and Growth Rate of Cephalosporins (2018-2023)

    • Table China Antibiotic Resistance Production Volume by Region (2018-2023)

    • Table China Antibiotic Resistance Production Volume Share by Region (2018-2023)

    • Figure China Antibiotic Resistance Production Volume Share by Region (2018-2023)

    • Table China Antibiotic Resistance Production Value by Region (2018-2023)

    • Table China Antibiotic Resistance Production Value Share by Region (2018-2023)

    • Figure China Antibiotic Resistance Production Value Share by Region (2018-2023)

    • Table China Antibiotic Resistance Sales Volume by Region (2018-2023)

    • Table China Antibiotic Resistance Sales Volume Share by Region (2018-2023)

    • Figure China Antibiotic Resistance Sales Volume Share by Region (2018-2023)

    • Table China Antibiotic Resistance Sales Value by Region (2018-2023)

    • Table China Antibiotic Resistance Sales Value Share by Region (2018-2023)

    • Figure China Antibiotic Resistance Sales Value Share by Region (2018-2023)

    • Table North China Antibiotic Resistance Production Volume by Type (2018-2023)

    • Table North China Antibiotic Resistance Production Volume Share by Type (2018-2023)

    • Figure North China Antibiotic Resistance Production Volume Share by Type (2018-2023)

    • Table North China Antibiotic Resistance Sales Volume by Application (2018-2023)

    • Table North China Antibiotic Resistance Sales Volume Share by Application (2018-2023)

    • Figure North China Antibiotic Resistance Sales Volume Share by Application (2018-2023)

    • Table Central China Antibiotic Resistance Production Volume by Type (2018-2023)

    • Table Central China Antibiotic Resistance Production Volume Share by Type (2018-2023)

    • Figure Central China Antibiotic Resistance Production Volume Share by Type (2018-2023)

    • Table Central China Antibiotic Resistance Sales Volume by Application (2018-2023)

    • Table Central China Antibiotic Resistance Sales Volume Share by Application (2018-2023)

    • Figure Central China Antibiotic Resistance Sales Volume Share by Application (2018-2023)

    • Table South China Antibiotic Resistance Production Volume by Type (2018-2023)

    • Table South China Antibiotic Resistance Production Volume Share by Type (2018-2023)

    • Figure South China Antibiotic Resistance Production Volume Share by Type (2018-2023)

    • Table South China Antibiotic Resistance Sales Volume by Application (2018-2023)

    • Table South China Antibiotic Resistance Sales Volume Share by Application (2018-2023)

    • Figure South China Antibiotic Resistance Sales Volume Share by Application (2018-2023)

    • Table East China Antibiotic Resistance Production Volume by Type (2018-2023)

    • Table East China Antibiotic Resistance Production Volume Share by Type (2018-2023)

    • Figure East China Antibiotic Resistance Production Volume Share by Type (2018-2023)

    • Table East China Antibiotic Resistance Sales Volume by Application (2018-2023)

    • Table East China Antibiotic Resistance Sales Volume Share by Application (2018-2023)

    • Figure East China Antibiotic Resistance Sales Volume Share by Application (2018-2023)

    • Table Northeast China Antibiotic Resistance Production Volume by Type (2018-2023)

    • Table Northeast China Antibiotic Resistance Production Volume Share by Type (2018-2023)

    • Figure Northeast China Antibiotic Resistance Production Volume Share by Type (2018-2023)

    • Table Northeast China Antibiotic Resistance Sales Volume by Application (2018-2023)

    • Table Northeast China Antibiotic Resistance Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Antibiotic Resistance Sales Volume Share by Application (2018-2023)

    • Table Southwest China Antibiotic Resistance Production Volume by Type (2018-2023)

    • Table Southwest China Antibiotic Resistance Production Volume Share by Type (2018-2023)

    • Figure Southwest China Antibiotic Resistance Production Volume Share by Type (2018-2023)

    • Table Southwest China Antibiotic Resistance Sales Volume by Application (2018-2023)

    • Table Southwest China Antibiotic Resistance Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Antibiotic Resistance Sales Volume Share by Application (2018-2023)

    • Table Northwest China Antibiotic Resistance Production Volume by Type (2018-2023)

    • Table Northwest China Antibiotic Resistance Production Volume Share by Type (2018-2023)

    • Figure Northwest China Antibiotic Resistance Production Volume Share by Type (2018-2023)

    • Table Northwest China Antibiotic Resistance Sales Volume by Application (2018-2023)

    • Table Northwest China Antibiotic Resistance Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Antibiotic Resistance Sales Volume Share by Application (2018-2023)

    • Table Tetraphase Pharmaceuticals Company Profile

    • Table Tetraphase Pharmaceuticals Antibiotic Resistance Revenue, Price and Gross (2018-2023)

    • Table Westway Health Company Profile

    • Table Westway Health Antibiotic Resistance Revenue, Price and Gross (2018-2023)

    • Table Melinta Therapeutics Company Profile

    • Table Melinta Therapeutics Antibiotic Resistance Revenue, Price and Gross (2018-2023)

    • Table Nabriva Therapeutics Company Profile

    • Table Nabriva Therapeutics Antibiotic Resistance Revenue, Price and Gross (2018-2023)

    • Table Macrolide Pharmaceuticals Company Profile

    • Table Macrolide Pharmaceuticals Antibiotic Resistance Revenue, Price and Gross (2018-2023)

    • Table Allergan Company Profile

    • Table Allergan Antibiotic Resistance Revenue, Price and Gross (2018-2023)

    • Table BioVersys GmbH Company Profile

    • Table BioVersys GmbH Antibiotic Resistance Revenue, Price and Gross (2018-2023)

    • Table Phage Technologies SA Company Profile

    • Table Phage Technologies SA Antibiotic Resistance Revenue, Price and Gross (2018-2023)

    • Table The Medicines Company Company Profile

    • Table The Medicines Company Antibiotic Resistance Revenue, Price and Gross (2018-2023)

    • Table Nemesis Bioscience Company Profile

    • Table Nemesis Bioscience Antibiotic Resistance Revenue, Price and Gross (2018-2023)

    • Table AmpliPhi Biosciences Company Profile

    • Table AmpliPhi Biosciences Antibiotic Resistance Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.